Pfizer Registry of Outcomes in Growth hormone RESearch (PROGRES): A Multi-Country Non-Interventional Prospective Cohort Study Among Patients with Human Growth Hormone (hGH) Treatments Under Routine Clinical Care

Brief description of study

This study will explore how safe and effective hGH treatments are in the long term. This study is “non-interventional” because it collects information only.

Clinical Study Identifier: s22-00028
Principal Investigator: Paul Saenger.
Other Investigator: Jorge Mejia-Corletto.

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.